1. Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals
   Chiara De Santi et al, 2017, Occupational and Environmental Medicine CrossRef
2. Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma?
   Rudy Foddis et al, 2022, Diagnostics CrossRef
3. A Novel Panel of Serum Biomarkers for MPM Diagnosis
   A. Bonotti et al, 2017, Disease Markers CrossRef
4. Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure
   Melike Demir et al, 2016, Lung CrossRef
5. Preoperative Serum Levels of Mesothelin in Patients with Colon Cancer
   Özgür Bostancı et al, 2014, Disease Markers CrossRef
6. Plasma Peptidome as a Source of Biomarkers for Diagnosis of Cholangiocarcinoma
   Kanawut Kotawong et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
7. Malignant mesothelioma as an oxidative stress-induced cancer: An update
   Shan Hwu Chew et al, 2015, Free Radical Biology and Medicine CrossRef
8. Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma
   Carmina Jiménez-Ramírez et al, 2019, Lung CrossRef
9. Peritoneal Malignant Mesothelioma with Epithelioid Type, Demonstrating High Serum and Ascitic KL-6 Levels: Immunohistochemical Analyses
   Saifun Nahar et al, 2015, Rare Tumors CrossRef
10. Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma
    Lory Santarelli et al, 2015, Lung Cancer CrossRef